Literature DB >> 9150735

Identification of a modifier gene locus on chromosome 1p35-36 in familial adenomatous polyposis.

Z Dobbie1, K Heinimann, D T Bishop, H Müller, R J Scott.   

Abstract

Phenotypic variability based on nonallelic heterogeneity is a characteristic feature of the dominantly inherited disease, familial adenomatous polyposis (FAP). A modifying locus, called Mom-1, which strongly influences disease expression has been mapped in the mouse model of FAP to the region of murine chromosome 4, which has synteny to human chromosome 1p35-36. In the present study, this chromosomal region was investigated by using 14 microsatellite markers within a large FAP kindred in which patients harbor the same germ-line mutation but show markedly different disease characteristics. The linkage program MLINK was used to determine whether any correlation exists between these markers and the development of extracolonic symptoms in polyposis coli patients. Depending on the mode of inheritance of the affected locus, a maximum lod score was observed for markers D1S211 and D1S197, reaching 2.08 and 1.77, respectively. The observed values obtained within one large FAP family are supportive of a phenotype-modifying locus within this chromosomal region.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150735     DOI: 10.1007/s004390050423

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  9 in total

1.  Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes.

Authors:  R Houlston; M Crabtree; R Phillips; M Crabtree; I Tomlinson
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

2.  Genotype-phenotype correlations in attenuated adenomatous polyposis coli.

Authors:  C Soravia; T Berk; L Madlensky; A Mitri; H Cheng; S Gallinger; Z Cohen; B Bapat
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

Review 3.  Gastroduodenal lesions in familial adenomatous polyposis.

Authors:  H Kashiwagi; A D Spigelman
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

4.  Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes.

Authors:  M D Crabtree; I P M Tomlinson; S V Hodgson; K Neale; R K S Phillips; R S Houlston
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

5.  Familial adenomatous polyposis: experience from a study of 1164 unrelated german polyposis patients.

Authors:  Waltraut Friedl; Stefan Aretz
Journal:  Hered Cancer Clin Pract       Date:  2005-09-15       Impact factor: 2.857

6.  Profuse familial adenomatous polyposis with an adenomatous polyposis coli exon 3 mutation.

Authors:  S Nasioulas; I T Jones; D J St John; R J Scott; S M Forrest; R J McKinlay Gardner
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

7.  Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene.

Authors:  Maria Elena Martinez; Thomas G O'Brien; Kimberly E Fultz; Naveen Babbar; Hagit Yerushalmi; Ning Qu; Yongjun Guo; David Boorman; Janine Einspahr; David S Alberts; Eugene W Gerner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-16       Impact factor: 11.205

8.  Thymic carcinoids in multiple endocrine neoplasia type 1.

Authors:  B T Teh; J Zedenius; S Kytölä; B Skogseid; J Trotter; H Choplin; S Twigg; F Farnebo; S Giraud; D Cameron; B Robinson; A Calender; C Larsson; P Salmela
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

9.  Aggressive mutation in a familial adenomatous polyposis syndrome family: when phenotype guides clinical surveillance.

Authors:  Florencia Neffa; Lucia Garcia; Adriana Della Valle; Florencia Carusso; Carolina Vergara; Daniel Sanchez; Marta Sapone; Noelia Silveyra; Ana Laura Revello; Patricia Esperon
Journal:  J Gastrointest Oncol       Date:  2018-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.